# Brain Monoamine Deficits in the CD Mouse Model of Williams-Beuren Syndrome

Chloé Aman, Hélène Gréa, Alicia Rousseau, Anne-Emilie Allain, Susanna

Pietropaolo, Philippe de Deurwaerdère, Valérie Lemaire

► To cite this version:

Chloé Aman, Hélène Gréa, Alicia Rousseau, Anne-Emilie Allain, Susanna Pietropaolo, et al. Brain Monoamine Deficits in the CD Mouse Model of Williams-Beuren Syndrome. Biomolecules, 2025, 15 (10), pp.1382. 10.3390/biom15101382. [hal-05363548](https://hal.science/hal-05363548v1)

HAL Id: hal-05363548

https://hal.science/hal-05363548v1

Submitted on 13 Nov 2025

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>

Distributed under a Creative Commons Attribution 4.0 International License
Article

# Brain Monoamine Deficits in the CD Mouse Model of Williams-Beuren Syndrome

Chloé Aman, Hélène Gréa ID, Alicia Rousseau, Anne-Emilie Allain, Susanna Pietropaolo ID,
Philippe De Deurwaerdère *ID and Valérie Lemaire

Institut de Neurosciences Cognitives et Intégratives (INCIA, UMR5287), Centre National de la Recherche Scientifique, Université de Bordeaux, F-33000 Bordeaux, France; chloe.aman@u-bordeaux.fr (C.A.); helene.grea@u-bordeaux.fr (H.G.); alicia.rousseau.alicia@gmail.com (A.R.); anne-emilie.allain@u-bordeaux.fr (A.-E.A.); susanna.pietropaolo@u-bordeaux.fr (S.P.); valerie.mayo@u-bordeaux.fr (V.L.)

* Correspondence: philippe.de-deurwaerdere@u-bordeaux.fr; Tel.: +33-557-571-551

## Abstract

Williams-Beuren Syndrome (WBS) is a rare neurodevelopmental disease caused by a microdeletion on chromosome 7 (7q11.23) and associated with behavioral disorders such as hypersociability, impaired visuospatial memory, anxiety, and motor disorders. The precise underlying neurobiological bases remain unknown. The CD mouse is a genetic model that reproduces the deletion found in WBS patients on the equivalent mouse locus. Taking into account that monoaminergic systems are known to modulate behaviors that are altered in WBS, we hypothesized that CD mice could present quantitative and qualitative changes in brain noradrenaline, dopamine, and serotonin systems compared to wild-type (WT) littermates. We sampled 10 brain regions in female mice for quantifying monoamines and related compounds by high-performance liquid chromatography coupled to electrochemical detection. We found a decrease in dopamine in the nucleus accumbens and serotonin and its metabolites in the hypothalamus. Using correlative approaches of tissue content across the brain, we found that the relationships between neurotransmitters or their metabolic ratios (metabolite/neurotransmitter) changed in CD compared to WT. Notably, compared to WT, the ratios in CD mice showed striatal correlations for the serotonin/dopamine systems interaction, and cortical, thalamic, and hypothalamic correlations for the noradrenaline/dopamine systems interaction. The data suggest specific alterations of monoaminergic systems across the brain that could sustain the abnormal behavioral responses displayed by CD mice.

**Keywords:** dopamine; serotonin; noradrenaline; connectivity; correlation; metabolism; neurochemistry; nucleus accumbens; cortex; hypothalamus

## 1. Introduction

Williams-Beuren syndrome (WBS) is a rare genetic disorder characterized by intellectual disability, heart defects, and distinctive physical and behavioral characteristics [1,2]. The behavioral profile of WBS individuals is characterized in particular by hypersociability, cognitive impairment of varying severity, and impaired visuospatial abilities. It also includes some motor disturbances that have been related to extrapyramidal signs [3]. The genetic mutation associated with this disorder is a microdeletion on chromosome 7, which contains several genes essential for neurosensory and cardiovascular functions [4]. Rare partial forms of WBS are linked to smaller deletions and patients with reciprocal

<figure><img src="image_2.png" /></figure>

check for
updates

Academic Editor: Eiichiro Nagata

Received: 25 August 2025

Revised: 17 September 2025

Accepted: 24 September 2025

Published: 28 September 2025

**Citation:** Aman, C.; Gréa, H.; Rousseau, A.; Allain, A.-E.; Pietropaolo, S.; De Deurwaerdère, P.; Lemaire, V. Brain Monoamine Deficits in the CD Mouse Model of Williams-Beuren Syndrome. *Biomolecules* **2025**, *15*, 1382. https://doi.org/10.3390/biom15101382

**Copyright:** © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
microduplication of the same 7q11.23 region have also been identified [5]. The genetic deletion results in the monoallelic loss of 28 genes, some of which have been identified including the transcription factor *gtf2ird1* [4,5], mostly involved in the neurobehavioral phenotype of WBS. The widespread nature of the behavioral alterations suggests that several neurobiological networks are altered [2,6], but this is still not well known.

A genetic mouse model mimics the complete heterozygous deletion found in humans with WBS. This "complete deletion" (CD) mouse model reproduces certain phenotypes frequently observed in WBS patients [7]. The CD mouse model, beyond cardiovascular abnormalities [7-9], displayed early and adult behavioral alterations including altered social interaction and communication, delayed sensory development, alteration of exploratory and anxiety-like behaviors, and sensorial sensitivity [7,10] as well as cognitive deficits in adulthood [11-15]. Like the human disease [16], these deficits were equally found in both CD male and female mice [14] with few sex-dependent effects, mostly observed in young mice only [10]. Thus, the model could permit to determine neurobiological alterations over several brain functional networks.

The monoamines noradrenaline (NA), dopamine (DA), and serotonin (5-HT) act as neuromodulators in the central nervous system (CNS) and participate in the organization and function of neurobiological networks during development and in adulthood. All these monoaminergic neurons diffusely project throughout the CNS from clusters of cell bodies located in the brainstem and regulate several behavioral functions [17-21]. Their dysregulation has been postulated in WBS patients, particularly for the DA system [3], but poorly studied either in humans or in animal models [11,22]. Tissue monoamine contents at rest allows for measuring quantities of monoamines and associated compounds (metabolites/precursors) in several brain structures, and approximating connectivity of monoaminergic function across sampled brain regions [23,24]. We therefore hypothesized that subtle dysregulations of monoamine contents and connectivity across several brain regions may be present in CD mice, possibly underlying their behavioral deficits.

In the present study, we assessed the post mortem brain distribution of NA, DA, and 5-HT and associated compounds in CD and WT adult mice. We selected 10 brain regions based on their involvement in the behavioral disorders found in this model (see Section 2.2). Tissue levels of monoamine as well as their metabolites and precursors were measured using high performance liquid chromatography coupled to electrochemical detection (HPLC-EC) technique.

**2. Materials and Methods**

2.1. *Animals*

A cohort of 7 CD mice and 9 WT female littermates, aged 7 months and behav-
iorally naive, was used for this study. They were obtained by crossing heterozygous CD
male mice bred in the animal facility of the University of Bordeaux with WT C57BL/6J
female mice purchased from Janvier (Le Genest-Saint-Isle, France; authorization # 34602-
2022011017347236 to S.P. from the Ethical Committee for Animal Experimentation of the
University of Bordeaux CEEA 050; 4 March 2022). The CD colony was derived from CD
breeders kindly provided to S.P. by Dr. Victoria Campuzano from Barcelona University.
The choice of the female sex and the number of animals were conditioned by limitations in
mouse availability. Despite these limitations, the well-known lack of major sex differences
in the behavioral phenotype of adult CD mice [14] was taken as one criterion to conduct
this neurochemical experiment in females only. The experiments were performed in an-
imals from a single cohort, as recommended by recent guidelines on brain monoamine
quantification [23]. Each mouse was marked at one week of age by a paw tattoo with a non-
toxic and odorless permanent ink and genotyped as previously described [10]. Mice were
group-housed since weaning under standard conditions (T°: 21 ± 1 °C, 12-h light/dark cycle, housed in polycarbonate cage enriched with nesting material) with access to water and food ad libitum.

## 2.2. *Selection of Brain Regions*

Mice were sacrificed one by one in an isolated room by cervical dislocation during the light phase. Their brains were immediately extracted and frozen in isopentane cooled by dry ice for 3 min. The brains were then stored in tubes at -80 °C. To sample the structures of interest, the brains were cut in the coronal plane in a cryostat at -22 °C. The following 10 regions were selected for our study: the prelimbic cortex (PL) for its role in planning and working memory; the orbitofrontal cortex (OF) for its involvement in social behaviors; the amygdala (A) for its role in anxiety; the auditory cortex (AuC) for its role in sound processing; the thalamus (T) for its sensory integration function; the ventral (vH) and dorsal (dH) hippocampus for their involvement in spatial memory encoding and retrieval; the nucleus accumbens (NAc) and striatum (STR) for their roles in motor planning and motivation; and the hypothalamus (Hy) for its key role in the interface between higher nervous functions and the periphery via the control of the autonomic system and social interactions. The different regions of interest were sampled as previously reported [25] with some modifications. The bilateral punches were made blind of the genotype using 600 µm stainless steel cannula for OF, PL, AuC, A, dH, vH, T, Hy, and 800 µm stainless steel cannula for NAc and STR. The samples were placed in pre-weighed 0.5 mL Eppendorf tubes. The tubes were then stored at -80 °C until the biochemical analysis.

## 2.3. *Neurochemical Analysis*

The HPLC-EC apparatus was composed of an HPLC column (Hypersyl, 15 cm × 4.6 mm, C.I.L. Sainte Foy la Grande, France) and a mobile phase as previously reported [26]. The mobile phase is composed of methanol (7%), triethylamine (100 µL/L), NaH₂PO₄ (70 mM), EDTA (0.1 mM), sodium octyl sulfate (100 mg/L), and deionized water (18.2 MΩ.cm), and the pH was adjusted (approximately 4.2) with phosphoric acid to achieve good separation between compounds. The mobile phase was filtered (0.22 µm) and was delivered at a flow rate of 1.3 mL/min using a pump (LC20AD, Shimadzu, Paris, France). Sample injection was performed using a manual injection valve (Rheodyne, model 7725i, C.I.L. Sainte Foy la Grande, France) equipped with a 20 µL loop. Compounds of interest were eluted at different retention times to the electrochemical detection cell equipped with oxidation and reduction electrodes set at 350 mV and -270 mV, respectively. The coulometric detector (Coulochem II, ESA, Paris, France) was connected to a computer via an interface (Ulyss, Azur 5.0, Datalys, Saint-Martin-d'Hères, France). Under these conditions it is possible to measure NA, DA, and 5-HT as well as their metabolites, vanylmandelic acid (VMA), dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and the precursors 3,4-dihydroxyphenylalanine (L-DOPA) and 5-hydroxytryptophan (5-HTP). The emphasis was given to the monoamines NA, DA, and 5-HT and the ratios DOPAC/DA, 5-HIAA/5-HT, and VMA/NA which correspond to indirect indexes of the neurotransmitter turnover rate. The chromatographic conditions were checked by calibrations with standards solution made at different concentrations depending on the regions studied.

On the day of the neurochemical analysis, the tubes containing the brain region of interest were removed from -80 °C and placed on ice. Each tube was wiped off its water and then reweighed on the same precision balance as for the pre-weighing to determine the mass of collected tissue. An amount of 100 µL of perchloric acid (HClO4, 0.1 N, 4 °C) was added to the tube and the tissue was homogenized by sonication and centrifuged for 30 min at 13,000 rpm at 4 °C. 10 µL of the supernatant was injected in the HPLC-EC system.
Samples were injected and analyzed blind to the animal genotype. The final amount of compound was normalized to the tissue weight expressed in mg.

## 2.4. Statistical Analysis

Data from the WT and CD groups were analyzed using the Grubbs test to eliminate possible outliers (only one outlier permitted). A Shapiro-Wilk normality test was performed to verify that the majority of the data followed a normal distribution in considering each compound and the different genotype. A Student's t-test was thus performed to compare the means of the two groups.

For correlations, the coefficient r of Pearson was used to study the correlations of the neurotransmitter content (or ratio) between brain regions for each genotype, alone or in combination with another neurotransmitter (or another ratio).

In all cases, the significance criterion was set at *p* value < 0.05. All statistical analyses were performed using GraphPad 9.0 software.

# 3. Results

## 3.1. *Quantitative Profile of Monoaminergic Systems Between WT and CD Mice in Different Brain Regions*

Quantitative analysis of the tissue levels of monoamines is reported in Figure 1 for the brain region analyzed.

<figure><img src="image_3.png" /><figcaption>**Figure 1.** Tissue content of monoamines (upper panels), respective metabolites (middle panels), and ratios (lower panels) in WT and CD mice. Bars of histogram (grey for WT; red for CD mice) represent the values (expressed in pg/mg, mean ± SEM) of monoamines (DA, NA, 5-HT) and their metabolites</figcaption></figure>
(DOPAC, VMA, 5-HIAA), and ratios (DOPAC/DA, VMA/NA, 5-HIAA/5-HT) for the ten explored brain regions (OF: orbitofrontal cortex, PL: prelimbic cortex, AuC: auditory cortex, A: amygdala, dH: dorsal hippocampus, vH: ventral hippocampus, NAc: nucleus accumbens, STR: striatum, T: thalamus, Hy: hypothalamus). For the dopaminergic system (left panels), all values in NAc and STR are represented on a separate graph due to the high concentration of DA and DOPAC in these structures (for the sake of homogeneity, DOPAC/DA ratios in NAc and STR are also represented apart). Tissue contents were compared using Student's t-test. \* *p*-value < 0.05, *n* = 7 (CD) and 9 (WT) animals/group. VMA was not measured in NAc and STR.

### 3.1.1. Dopaminergic System

The tissue levels of DA were similar for both genotypes in several brain regions. They were lower in the amygdala, nucleus accumbens and striatum of CD mice when compared to WT mice, but the difference was significant in nucleus accumbens only (Figure 1, upper left panel, DA: WT = 3042 ± 412 pg/mg, CD = 1718 ± 396 pg/mg, *p* = 0.04). However, no statistical difference was reported for its two metabolites (DOPAC: WT = 2360 ± 502 pg/mg, CD = 1985 ± 745 pg/mg, NS; HVA: WT = 625 ± 73 pg/mg, CD = 589 ± 115 pg/mg, NS; Supplementary File, Figure S1). A significant decrease in DOPAC was observed in prelimbic cortex in CD mice when compared to WT mice (Figure 1, middle left panel, DOPAC: WT = 31 ± 4 pg/mg, CD = 20 ± 2 pg/mg, *p* = 0.044). Moreover, HVA tissue content was significantly lower in the ventral hippocampus of CD mice (Supplementary File Figure S1, left panel, HVA: WT = 29 ± 3 pg/mg, CD = 20 ± 2 pg/mg, *p* = 0.042). The DOPAC/DA ratio in nucleus accumbens tended to be higher in CD mice without reaching statistical significance (DOPAC/DA: WT = 0.88 ± 0.2, CD = 1.15 ± 0.3, NS). In prelimbic cortex, however, DOPAC/DA ratio was significantly lower in CD mice when compared to WT mice (Figure 1, lower left panel, DOPAC/DA: WT = 3.16 ± 0.3, CD = 2.09 ± 0.3, *p* = 0.031). Finally, the levels of L-DOPA were similar in WT and CD mice in all explored brain regions (Supplementary File Figure S1, middle panel).

### 3.1.2. Noradrenergic System

NA tissue contents were similar in all brain regions explored between WT and CD mice (Figure 1, upper middle panel). However, the tissue level of the NA metabolite VMA was higher in the thalamus in CD mice (Figure 1, middle panel, VMA: WT = 316 ± 37 pg/mg, CD = 506 ± 68 pg/mg, *p* = 0.024). Finally, the ratio VMA/NA was similar between CD and WT mice for all explored brain regions (Figure 1, lower middle panel).

### 3.1.3. Serotonergic System

The 5-HT tissue contents were similar between WT and CD mice in all explored brain regions except in the hypothalamus where they were lower in CD mice when compared to WT mice (Figure 1, right upper panel, 5-HT: WT = 148 ± 13 pg/mg, CD = 97 ± 10 pg/mg, *p* = 0.02). In the hypothalamus, both precursor 5-HTP and metabolite 5-HIAA were decreased in CD mice (for 5-HTP see Supplementary File Figure S1, right panel, 5-HTP: WT = 7.9 ± 0.97 pg/mg, CD = 4.3 ± 0.52 pg/mg, *p* = 0.0118; for 5-HIAA see Figure 1. Right middle panel, WT = 116 ± 10 pg/mg, CD = 83 ± 8 pg/mg, *p* = 0.034). Finally, the ratio 5-HIAA/5-HT was similar between WT and CD mice in all considered brain regions (Figure 1, lower right panel).

## 3.2. Correlative Profile of Monoaminergic Systems Between the Different Brain Regions for WT and CD Mice

We first determined whether related compounds (neurotransmitter versus metabolite, or two connected metabolites) showed some correlations in each single brain region to determine the consistency of the dataset. The proportion of brain regions with signifi-
cant correlations between metabolically related compounds reached between 40 and 70% (Supplementary File, Figure S2). The pattern of these relationships was slightly different in WT and CD mice. This proportion for VMA/NA, not previously described, slightly increased in CD mice.

To fully estimate the neurochemical changes associated with CD genotype, correlative analyses were performed for each monoamine and their turnover among the 10 brain regions shown previously. For monoamines, only a few correlations were found (around two correlations), with no correlation for 5-HT in the WT group (Figure 2, upper panels). Changes in the number of correlations were observed for CD genotype, mostly for 5-HT. No clear regional pattern was noticed for either group. In contrast, more correlations were present for the turnovers with a higher number of correlations found for DOPAC/DA ratio in WT, involving both amygdala and striatum (A and STR: 3 correlations) (Figure 2, lower panels). In CD mice, the neurochemical pattern was altered for all turnovers. A specific alteration of the regional pattern was found for DOPAC/DA ratio with a suppression of the amygdala correlations towards other correlations including thalamus and hypothalamus.

<figure><img src="image_4.png" /><figcaption>**Figure 2.** Correlative profile of monoaminergic systems between different brain regions for WT and CD mice. Correlative analysis of tissue content and turnover index (ratio) for the dopaminergic system (DA, DOPAC/DA), noradrenergic system (NA, VMA/NA), and serotonergic system (5-HT, 5-HIAA/5-HT) among the 10 brain regions studied for WT and CD mice (OF: orbitofrontal cortex, PL: prelimbic cortex, AuC: auditory cortex, A: amygdala, dH: dorsal hippocampus, vH: ventral hippocampus, NAc: nucleus accumbens, STR: striatum, T: thalamus, Hy: hypothalamus). Each colored square corresponds to a significant correlation (*p* < 0.05, *r* Pearson's coefficient) with the color indicating the direction of the correlation (blue: negative, red: positive). The color gradient corresponds to the strength of the correlation (R values). VMA was not measured in STR and NAc, reducing to eight the number of regions for the ratio VMA/NA.</figcaption></figure>

### 3.3. Correlative Profile of Monoaminergic Systems Interaction Between the Different Brain Regions for WT and CD Mice

Furthermore, we explored the interaction of the monoaminergic systems through correlation matrix of different combinations of monoaminergic systems across sampled brain regions. For the combination of monoamines, only a few correlations were found, with a higher proportion between DA and 5-HT or NA and 5-HT (nine correlations in WT)
(Figure 3, upper panels). Reduced number of correlations and altered profile of correlations were reported for the correlations between 5-HT and DA in CD mice. Compared to WT mice, no correlation involving the nucleus accumbens, thalamus, or dorsal hippocampus was observed while those correlations involving the striatum were still present but one of them with a negative direction (STR/vH). The correlations between 5-HT and NA were quite maintained in the same brain regions (diagonal), but the other correlations changed. The correlations between NA and DA were approximately similar in number but only one in dorsal hippocampus was observed in both genotypes (Figure 3, upper panels, right side).

<figure><img src="image_5.png" /><figcaption>**Figure 3.** Correlative profile of monoaminergic systems between different brain regions and monoamine systems for WT and CD mice. Correlation matrix of tissue content and turnover index (ratio) between dopaminergic and serotonergic system (5-HT vs. DA, 5-HIAA/5-HT vs. DOPAC/DA), noradrenergic and serotonergic system (5-HT vs. NA, 5-HIAA/5-HT vs. VMA/NA), noradrenergic and dopaminergic system (DA vs. NA, DOPAC/DA vs. VMA/NA) in the eight or ten brain regions studied for WT and CD mice (OF: orbitofrontal cortex, PL: prelimbic cortex, AuC: auditory cortex, A: amygdala, dH: dorsal hippocampus, vH: ventral hippocampus, NAc: nucleus accumbens, STR: striatum, T: thalamus, Hy: hypothalamus). Each colored square corresponds to a significative correlation (*p* < 0.05, r Pearson's coefficient) with the color indicating the direction of the correlation (blue: negative; red: positive). The color gradient corresponds to the strength of the correlation (R values).</figcaption></figure>

The analysis of the ratios across the brain suggests the presence of distinct alterations of the regional pattern in WT and CD genotypes (Figure 3, lower panels). For the interaction between 5-HT and DA ratios in WT, the correlations, all positive, mostly involved the orbitofrontal cortex, thalamus, and hypothalamus. In CD mice, the correlations between DA and 5-HT mostly involved the striatum and the nucleus accumbens. For 5-HT and NA ratios interaction, the correlations were limited to NA in ventral hippocampus with subcortical 5-HT. The sole correlation in CD mice (in vH/T) was inverted with respect to WT. The correlations between DOPAC/DA and VMA/NA were few, mostly in the ventral hippocampus and the dorsal hippocampus in subcortical regions. The pattern was more widespread in CD mice including cortical regions, amygdala, and hypothalamus, with a higher proportion of negative correlations (Figure 3, lower panels, right side).
4. Discussion

The results show specific alterations in monoamine quantities, subtle and restricted to a few brain regions. These slight alterations are also associated with a reorganization of the connectivity of monoaminergic systems. The results support the hypothesis that monoaminergic systems are modified both quantitatively and qualitatively in the CD mouse model of WBS.

The quantities of monoamines, metabolites, and precursors measured in the different brain areas were heterogeneous, mostly for the DA system, and were in the expected range of their concentration [25–27]. In quantitative terms, both the DA and the 5-HT systems displayed specific deficits in CD mice with respect to the NA system. For the latter, only the metabolite VMA was markedly increased in the thalamus of CD mice. The lower values for DA in the nucleus accumbens might not be related to a lower number of DA neurons in the ventral tegmental area because it was not associated with the modification of levels of DOPAC, HVA, and the DOPAC/DA ratio. This reduced DA tone may underlie the deficits in motor functions observed in adult CD mice of both sexes in the rotarod test [7,14].

The deficits in 5-HT, as well as its precursor 5-HTP and its metabolite 5-HIAA were restricted to the hypothalamus. The decrease in 5-HT specifically in the hypothalamus is putatively not associated with reduction of 5-HT neurons in raphe nuclei either. The anatomical data suggest some kind of specificity of the distribution of 5-HT neurons and their projections [28–30], but the neurons that innervate the hypothalamus are also innervating other brain regions we sampled. Moreover, it has been reported that the autoradiographic labelling of the 5-HT transporter using [125I]RTI-55 was not modified in CD mice, including the hypothalamus [11]. Our data are different from a previous study in mice lacking only one WBS gene, i.e., coding for the transcription factor *gtf2ird1* [31], describing a slight increase in the levels of 5-HIAA, but not 5-HT, in some cortical regions and the amygdala [22]. However, the comparison with the CD mouse line is difficult because the monogenic *gtf2ird1* model does not reproduce several features of WBS and is based on a different genetic background. Thus, the decrease of 5-HT levels in CD mice could correspond to lower activity of the whole metabolic pathway of 5-HT terminals in the hypothalamus, perhaps related to local changes with neurochemical partners.

The specific alterations in tissue levels of monoamines in CD mice are unique and could impact the whole neuromodulatory spectrum of monoamines in the brain. The only way to address this possibility to date is to study the connectivity of monoaminergic neurochemical markers across the brain via correlative analyses [23,24]. The data show a distinct profile of correlations between WT and CD mice across the brain notably as regards the dopaminergic system, alone or in combination with the serotonergic or noradrenergic system. As the data were obtained from mice at rest, it seems that the correlations of the ratios offer more informative value than the neurotransmitters themselves or their metabolites [32]. Of note, the proportion of correlations between the neurotransmitter and its metabolite in single brain region (Supplementary File, Figure S2) was similar to that previously reported in mice [25] or rats [32,33]. It reached approximately 50% of brain regions with significant correlations. It was lower for the link between VMA and NA acknowledging that VMA is one of the four metabolites of NA, and perhaps not the main one [34]. While the proportion of the metabolic link for DA and 5-HT systems was similar (50%) in both genotypes, the pattern slightly changed in CD mice. For NA and VMA, the proportion increased, suggesting higher coherence of the metabolic activity for NA terminals in CD mice.

The correlations of the DOPAC/DA ratio were reduced across the brain, but their pattern in balance with the 5-HIAA/5-HT ratio evolved from widespread in WT to nucleus accumbens/striatum distribution in CD mice. An opposite organization was seen for the
interaction between DOPAC/DA and VMA/NA, where correlative links centered in the
hippocampus and thalamus in WT became more widespread in CD mice. Overall, these
changes of correlation patterns for the neuromodulatory systems in CD mice suggest a
distinct involvement of neurobiological networks in behavioral strategies compared to WT,
potentially associated with altered behavioral traits [23].

The behavioral deficits displayed by CD mice involve a large variety of domains [7,10],
and can be observed since early life phases [10] throughout adulthood [7,9,12–15]. It is
not our intent to discuss all of them in view of our data. The possible interference of the
monoaminergic profile we report could speculatively concern alteration of exploratory
behaviors, altered social interaction and communication, and sensorial sensitivity. Re-
garding the former, the decrease in accumbal DA content, often associated with reduced
motivation, reward, and/or lower motor responses [18,21] is in line with the reduced loco-
motor activity described in the open field test in adult CD mice [14]. It is noteworthy that
DOPAC/DA in prelimbic cortex, known to be increased after acute electric shock or open
field in mice [35,36], is decreased in CD mice, presumably revealing lower DA cortical tone.
This deficit could favor subcortical DA tone, but this one is limited by lower availability
of accumbal DA. We recently reported that exploratory behavior in mice was associated
with an increase in DA correlations organized around the prelimbic and cingulate cortex,
striatum and nucleus accumbens, the ventral tegmental area, and the cerebellum over
28 sampled regions [27]. Therefore, lower DA tissue content in the nucleus accumbens
and DOPAC/DA in the prefrontal cortex suggest altered capability of mesocorticolimbic
neurons to respond to cues in novel environmental demands, which could include social
cues as suggested previously [11]. The deficits in DA could also sustain impaired fear
responses in a conditioned fear task [11].

Regarding the hypersocial behavior, the decrease in hypothalamic 5-HT metabolic activity, possibly in association with the lower accumbal DA levels evoked above, could participate in the heightened social, affiliative behavior [10]. Indeed, the hypothalamus, particularly in its ventral parts, is involved with numerous brain regions in social behavior, interaction with congeners, and aggressiveness [37-40]. It is not intuitive as low 5-HT level is often associated with aggressiveness [41], but it is remarkable that the decrease in 5-HT occurred only in CD mice. Intriguingly, increased DOPAC/DA were described in the cortex, striatum, and hippocampus [42,43] of the *Fmr1*-KO mouse model of autism spectrum disorder, characterized by social deficits opposite to the hypersociability of CD mice [44]. Thus, the decrease in 5-HT biochemical activity in the hypothalamus can offer other perspectives on the link between 5-HT, social behavior, and hypothalamus. The nucleus accumbens also play a role in modulating affiliative behaviors with a possible involvement of 5-HT [45]. The higher proportion of correlations of the DA and 5-HT ratios in the nucleus accumbens and the striatum of CD mice might be a tribute to such a hypothesis.

The last comment concerns the higher sensorial sensitivity of CD mice marked no-
tably by higher auditory acuity [46]. The neurochemical study indicates that NA activity
is not deficient in CD mice, NA neurons being strongly involved in sensory responses
and arousal [19,47,48]. The anticipated lower DA responses to novel environment would
enhance the brain NA responses to sensory stimuli, the NA systems participating also in ex-
ploratory behavior with distinct fingerprint compared to DA [27]. Concerning hyperacusis,
we selected the auditory cortex, but we report no quantitative changes of monoaminergic
systems, and saw only changes in correlative profiles between CD and WT.

The neurochemical dataset could have beneficiated with a higher number of animals,
which corresponded here to the minimum number of observations we previously fixed
arbitrarily [23]. A larger sample size would have been necessary to correlate monoamine
levels with the behavioral alterations of CD mice, an issue that was beyond the scope
of our study, lying in the evaluation of baseline monoamine function in behaviorally
naïve mice. An additional limitation of our study was the lack of experiments in age-
matched male animals which were not available. The behavioral alterations are similar
in CD males and females at adulthood [7,14], but we cannot fully exclude sex-dependent
differences in brain monoaminergic alterations. Nonetheless, our findings provide the
first proof of evidence of the presence of specific alterations of monoaminergic function
in the CD mouse model of WBS. These data complete with neurochemical results the
anatomical and electrophysiological data showing altered development of neurons in
several brain regions [7,10], or synaptic plasticity in hippocampus [12]. These changes
suggest a modification of brain functioning in CD mice at rest and are in line with the
abnormal coordination of brain regions that has been hypothesized in WBS.

**5. Conclusions**

Our findings show that female CD mice display specific alterations of monoamine
content as well as a modification of the patterns of correlations among the different brain
regions. The DA defects seem to be pivotal for the remodeling of the connectivity of
monoaminergic systems. This study constitutes the first evidence of a modification of
monoaminergic systems in the CD model of WBS that could play a role in the numerous
behavioral disturbances reported in the CD model. One may further these data by ad-
dressing the neurochemistry of monoaminergic systems during neurodevelopment because
behavioral alterations occur early in both males and females. It would be required in
view of considering monoaminergic-based medication in WBS to mitigate monoaminergic
imbalance we report, possibly largely before adulthood.

**Supplementary Materials:** The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/biom15101382/s1, One supplementary file contains two figures corresponding to additional data that are not shown in the main text. The Figure S1 reports the concentration of HVA, L-DOPA and 5-HTP in the studied brain regions of WT and CD mice. The Figure S2 reports the correlative link between the neurotransmitter and its metabolite in single brain regions of WT and CD mice.

**Author Contributions:** Conceptualization, V.L. and P.D.D.; methodology, P.D.D. and A.-E.A.; software, C.A., H.G. and A.R.; validation, C.A., H.G., P.D.D. and V.L.; formal analysis, C.A., H.G. and A.R.; investigation, C.A., A.-E.A. and A.R.; resources, S.P., V.L. and P.D.D.; data curation, H.G.; writing—original draft preparation, C.A., V.L. and P.D.D.; writing—review and editing, C.A., V.L., H.G., S.P. and P.D.D.; visualization, V.L.; supervision, P.D.D. and V.L.; project administration, P.D.D. and V.L.; funding acquisition, V.L. and S.P. All authors have read and agreed to the published version of the manuscript.

**Funding:** The associations "Autour de Williams" and "Federation Williams France" provided financial support to S.P.

**Institutional Review Board Statement:** All procedures for animals followed the European Committee Council directives (2010/63/EU) and were conducted in accordance with the Ethical Committee for Animal Experimentation of the University of Bordeaux (CEEA-050), and were validated by the French Ministry for Higher Education, Research, and Innovation under the protocol code #34602-2022011017347236 (approval date: 4 March 2022).

**Informed Consent Statement:** Not applicable.

**Data Availability Statement:** The dataset is available upon request.

**Acknowledgments:** This work was supported by the French government in the framework of the University of Bordeaux's IdEx "Investments for the Future" program/GPR BRAIN_2030. C.A.
was the recipient of a grant from the «Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation». The authors thank Victoria Campuzano (Barcelona University, Spain) for kindly providing the CD mouse line to S.P. The authors thank the Functional Neurochemistry facility (INCIA). We also thank the CIRCE (Behavioral Engineering Centre) facility of Bordeaux Neurocampus for animal care and management of the breeding.

**Conflicts of Interest:** The authors declare no conflicts of interest.

**Abbreviations**

The following abbreviations are used in this manuscript:

<table><tr><td>5-HIAA</td><td>5-hydroxyindoleacetic acid</td></tr><tr><td>5-HT</td><td>5-hydroxytryptamine</td></tr><tr><td>5-HTP</td><td>5-hydroxytryptophan</td></tr><tr><td>A</td><td>Amygdala</td></tr><tr><td>AuC</td><td>Auditory cortex</td></tr><tr><td>CD</td><td>Complete deletion</td></tr><tr><td>CNS</td><td>Central nervous system</td></tr><tr><td>DA</td><td>Dopamine</td></tr><tr><td>dH</td><td>Dorsal hippocampus</td></tr><tr><td>DOPAC</td><td>3,4-Dihydroxyphenylacetic acid</td></tr><tr><td>HPLC</td><td>High pressure liquid chromatography</td></tr><tr><td>HVA</td><td>Homovanillic acid</td></tr><tr><td>Hy</td><td>Hypothalamus</td></tr><tr><td>L-DOPA</td><td>L-3,4-dihydroxyphenylalanine</td></tr><tr><td>NA</td><td>Noradrenaline</td></tr><tr><td>NAc</td><td>Nucleus accumbens</td></tr><tr><td>OF</td><td>Orbitofrontal Cortex</td></tr><tr><td>PL</td><td>Prelimbic Cortex</td></tr><tr><td>STR</td><td>Striatum</td></tr><tr><td>T</td><td>Thalamus</td></tr><tr><td>vH</td><td>Ventral hippocampus</td></tr><tr><td>VMA</td><td>Vanillylmandelic acid</td></tr><tr><td>WBS</td><td>Williams-Beuren Syndrome</td></tr><tr><td>WT</td><td>Wild type</td></tr></table>

**References**

1. Martens, M.A.; Wilson, S.J.; Reutens, D.C. Research Review: Williams syndrome: A critical review of the cognitive, behavioral, and neuroanatomical phenotype. *J. Child. Psychol. Psychiatry* **2008**, *49*, 576–608. [CrossRef]

2. Pober, B.R. Williams-Beuren syndrome. *N. Engl. J. Med.* **2010**, *362*, 239–252. [CrossRef]

3. Gagliardi, C.; Martelli, S.; Burt, M.D.; Borgatti, R. Evolution of Neurologic Features in Williams Syndrome. *Pediatr. Neurol.* **2007**, *36*, 301–306. [CrossRef]

4. Schubert, C. The genomic basis of the Williams-Beuren syndrome. *Cell Mol. Life Sci.* **2009**, *66*, 1178–1197. [CrossRef]

5. Merla, G.; Brunetti-Pierri, N.; Micale, L.; Fusco, C. Copy number variants at Williams-Beuren syndrome 7q11.23 region. *Hum. Genet.* **2010**, *128*, 3–26. [CrossRef]

6. Fan, C.C.; Brown, T.T.; Bartsch, H.; Kuperman, J.M.; Hagler, D.J.; Schork, A.; Searcy, Y.; Bellugi, U.; Halgren, E.; Dale, A.M. Williams syndrome-specific neuroanatomical profile and its associations with behavioral features. *Neuroimage Clin.* **2017**, *15*, 343–347. [CrossRef]

7. Segura-Puimedon, M.; Sahún, I.; Velot, E.; Dubus, P.; Borralleras, C.; Rodrigues, A.J.; Valero, M.C.; Valverde, O.; Sousa, N.; Herault, Y.; et al. Heterozygous deletion of the Williams-Beuren syndrome critical interval in mice recapitulates most features of the human disorder. *Human. Mol. Genet.* **2014**, *23*, 6481–6494. [CrossRef] [PubMed]

8. Abdalla, N.; Ortiz-Romero, P.; Rodriguez-Rovira, I.; Pérez-Jurado, L.A.; Egea, G.; Campuzano, V. The Combined Treatment of Curcumin with Verapamil Ameliorates the Cardiovascular Pathology in a Williams-Beuren Syndrome Mouse Model. *Int. J. Mol. Sci.* **2023**, *24*, 3261. [CrossRef] [PubMed]
9. Jiménez-Altayó, F.; Ortiz-Romero, P.; Puertas-Umbert, L.; Dantas, A.P.; Pérez, B.; Vila, E.; D'Ocon, P.; Campuzano, V. Stenosis coexists with compromised α1-adrenergic contractions in the ascending aorta of a mouse model of Williams-Beuren syndrome. *Sci. Rep.* **2020**, *10*, 889. [CrossRef] [PubMed]

10. Giannoccaro, S.; Ferraguto, C.; Petroni, V.; Marcelly, C.; Nogues, X.; Campuzano, V.; Pietropaolo, S. Early Neurobehavioral Characterization of the CD Mouse Model of Williams-Beuren Syndrome. *Cells* **2023**, *12*, 391. [CrossRef]

11. Nygaard, K.R.; Swift, R.G.; Glick, R.M.; Wagner, R.E.; Maloney, S.E.; Gould, G.G.; Dougherty, J.D. Oxytocin receptor activation does not mediate associative fear deficits in a Williams Syndrome model. *Genes. Brain Behav.* **2021**, *21*, e12750. [CrossRef]

12. Borralleras, C.; Mato, S.; Amédée, T.; Matute, C.; Mulle, C.; Pérez-Jurado, L.A.; Campuzano, V. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome. *Mol. Brain* **2016**, *9*, 76. [CrossRef]

13. Borralleras, C.; Sahun, I.; Pérez-Jurado, L.A.; Campuzano, V. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome. *Mol. Ther.* **2015**, *23*, 1691–1699. [CrossRef]

14. Piquemal, M.; Abdulkarim-Abdalla, N.; Ortiz-Romero, P.; Lemaire-Mayo, V.; Crusio, W.E.; Louette, E.; Campuzano, V.; Pietropaolo, S. Chlorzoxazone, A BKCa Channel Agonist, Rescues The Pathological Phenotypes Of Williams-Beuren Syndrome In A Preclinical Model. *bioRxiv* **2020**. [CrossRef]

15. Navarro-Romero, A.; Galera-López, L.; Ortiz-Romero, P.; Llorente-Ovejero, A.; de Los Reyes-Ramírez, L.; Bengoetxea de Tena, I.; Garcia-Elias, A.; Mas-Stachurska, A.; Reixachs-Solé, M.; Pastor, A.; et al. Cannabinoid signaling modulation through JZL184 restores key phenotypes of a mouse model for Williams-Beuren syndrome. *Elife* **2022**, *11*, e72560. [CrossRef]

16. Porter, M.A.; Dodd, H.; Cairns, D. Psychopathological and behavior impairments in Williams-Beuren syndrome: The influence of gender, chronological age, and cognition. *Child Neuropsychol.* **2009**, *15*, 359–374. [CrossRef] [PubMed]

17. Bacqué-Cazenave, J.; Bharatiya, R.; Barrière, G.; Delbecque, J.-P.; Bouguiyoud, N.; Di Giovanni, G.; Cattaert, D.; De Deurwaerdère, P. Serotonin in Animal Cognition and Behavior. *Int. J. Mol. Sci.* **2020**, *21*, 1649. [CrossRef]

18. De Deurwaerdère, P.; Di Giovanni, G. Serotonergic modulation of the activity of mesencephalic dopaminergic systems: Therapeutic implications. *Prog. Neurobiol.* **2017**, *151*, 175–236. [CrossRef] [PubMed]

19. Aston-Jones, G.; Bloom, F.E. Norepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli. *J. Neurosci.* **1981**, *1*, 887–900. [CrossRef]

20. Aston-Jones, G.; Rajkowski, J.; Cohen, J. Role of locus coeruleus in attention and behavioral flexibility. *Biol. Psychiatry* **1999**, *46*, 1309–1320. [CrossRef] [PubMed]

21. Le Moal, M.; Simon, H. Mesocorticolimbic dopaminergic network: Functional and regulatory roles. *Physiol. Rev.* **1991**, *71*, 155–234. [CrossRef]

22. Young, E.J.; Lipina, T.; Tam, E.; Mandel, A.; Clapcote, S.J.; Bechard, A.R.; Chambers, J.; Mount, H.T.J.; Fletcher, P.J.; Roder, J.C.; et al. Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. *Genes Brain Behav.* **2008**, *7*, 224–234. [CrossRef] [PubMed]

23. Butler, J.J.; Aman, C.; Rivalan, M.; Fitoussi, A.; Parrot, S.; Dellu-Hagedorn, F.; De Deurwaerdère, P. Neurochemical Assessment of Tissue Levels of Neurotransmitters for Approximating Neurotransmitter System Connectivity. *ACS Chem. Neurosci.* **2025**, *16*, 1243–1246. [CrossRef]

24. Fitoussi, A.; Dellu-Hagedorn, F.; De Deurwaerdère, P. Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition. *Neuroscience* **2013**, *255*, 233–245. [CrossRef] [PubMed]

25. Marty, V.; Butler, J.J.; Coutens, B.; Chargui, O.; Chagraoui, A.; Guiard, B.P.; De Deurwaerdère, P.; Cavaillé, J. Deleting Snord115 genes in mice remodels monoaminergic systems activity in the brain toward cortico-subcortical imbalances. *Hum. Mol. Genet.* **2023**, *32*, 244–261. [CrossRef]

26. Puginier, E.; Bharatiya, R.; Chagraoui, A.; Manem, J.; Cho, Y.H.; Garret, M.; De Deurwaerdère, P. Early neurochemical modifications of monoaminergic systems in the R6/1 mouse model of Huntington's disease. *Neurochem. Int.* **2019**, *128*, 186–195. [CrossRef]

27. Butler, J.J.; Virgili, M.; Di Giovanni, G.; Chagraoui, A.; Beyeler, A.; De Deurwaerdère, P. 5-HT2A receptors shape whole-brain monoaminergic coherence in male mice. *Prog. Neuro-psychopharmacol. Biol. Psychiatry* **2025**, *141*, 111437. [CrossRef]

28. Hornung, J.-P. The human raphe nuclei and the serotonergic system. *J. Chem. Neuroanat.* **2003**, *26*, 331–343. [CrossRef]

29. Ren, J.; Friedmann, D.; Xiong, J.; Liu, C.D.; Ferguson, B.R.; Weerakkody, T.; DeLoach, K.E.; Ran, C.; Pun, A.; Sun, Y.; et al. Anatomically Defined and Functionally Distinct Dorsal Raphe Serotonin Sub-systems. *Cell* **2018**, *175*, 472–487.e20. [CrossRef] [PubMed]

30. Ren, J.; Isakova, A.; Friedmann, D.; Zeng, J.; Grutzner, S.M.; Pun, A.; Zhao, G.Q.; Kolluru, S.S.; Wang, R.; Lin, R.; et al. Single-cell transcriptomes and whole-brain projections of serotonin neurons in the mouse dorsal and median raphe nuclei. *Elife* **2019**, *8*, e49424. [CrossRef]

31. Antonell, A.; Del Campo, M.; Magano, L.F.; Kaufmann, L.; de la Iglesia, J.M.; Gallastegui, F.; Flores, R.; Schweigmann, U.; Fauth, C.; Kotzot, D.; et al. Partial 7q11.23 deletions further implicate GTF2I and GTF2IRD1 as the main genes responsible for the Williams-Beuren syndrome neurocognitive profile. *J. Med. Genet.* **2010**, *47*, 312–320. [CrossRef] [PubMed]
32. Dellu-Hagedorn, F.; Fitoussi, A.; De Deurwaerdère, P. Correlative analysis of dopaminergic and serotonergic metabolism across the brain to study monoaminergic function and interaction. *J. Neurosci. Methods* **2017**, *280*, 54–63. [CrossRef] [PubMed]

33. Gros, A.; Lavenu, L.; Morel, J.L.; De Deurwaerdère, P. Simulated Microgravity Subtlety Changes Monoamine Function across the Rat Brain. *Int. J. Mol. Sci.* **2021**, *22*, 11759. [CrossRef]

34. Eisenhofer, G.; Kopin, I.J.; Goldstein, D.S. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. *Pharmacol. Rev.* **2004**, *56*, 331–349. [CrossRef]

35. Hervé, D.; Tassin, J.P.; Barthelemy, C.; Blanc, G.; Lavielle, S.; Glowinski, J. Difference in the reactivity of the mesocortical dopaminergic neurons to stress in the BALB/C and C57 BL/6 mice. *Life Sci.* **1979**, *25*, 1659–1664. [CrossRef]

36. Tassin, J.P.; Herve, D.; Blanc, G.; Glowinski, J. Differential effects of a two-minute open-field session on dopamine utilization in the frontal cortices of BALB/C and C57 BL/6 mice. *Neurosci. Lett.* **1980**, *17*, 67–71. [CrossRef] [PubMed]

37. Siegel, A.; Roeling, T.A.; Gregg, T.R.; Kruk, M.R. Neuropharmacology of brain-stimulation-evoked aggression. *Neurosci. Biobehav. Rev.* **1999**, *23*, 359–389. [CrossRef]

38. Vazquez-Borsetti, P.; Celada, P.; Cortes, R.; Artigas, F. Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei. *Int. J. Neuropsychopharmacol.* **2011**, *14*, 289–302. [CrossRef]

39. Silva, B.A.; Mattucci, C.; Krzywkowski, P.; Murana, E.; Illarionova, A.; Grinevich, V.; Canteras, N.S.; Ragozzino, D.; Gross, C.T. Independent hypothalamic circuits for social and predator fear. *Nat. Neurosci.* **2013**, *16*, 1731–1733. [CrossRef]

40. Krzywkowski, P.; Penna, B.; Gross, C.T. Dynamic encoding of social threat and spatial context in the hypothalamus. *Elife* **2020**, *9*, e57148. [CrossRef]

41. Kästner, N.; Richter, S.H.; Urbanik, S.; Kunert, J.; Waider, J.; Lesch, K.-P.; Kaiser, S.; Sachser, N. Brain serotonin deficiency affects female aggression. *Sci. Rep.* **2019**, *9*, 1366. [CrossRef] [PubMed]

42. Gruss, M.; Braun, K. Alterations of amino acids and monoamine metabolism in male Fmr1 knockout mice: A putative animal model of the human fragile X mental retardation syndrome. *Neural Plast.* **2001**, *8*, 285–298. [CrossRef]

43. Gruss, M.; Braun, K. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice. *Neurochem. Int.* **2004**, *45*, 81–88. [CrossRef]

44. Tager-Flusberg, H.; Skwerer, D.P.; Joseph, R.M. Model syndromes for investigating social cognitive and affective neuroscience: A comparison of autism and Williams syndrome. *Soc. Cogn. Affect. Neurosci.* **2006**, *1*, 175–182. [CrossRef]

45. Borland, J.M. A review of the effects of different types of social behaviors on the recruitment of neuropeptides and neurotransmitters in the nucleus accumbens. *Front. Neuroendocrinol.* **2025**, *77*, 101175. [CrossRef] [PubMed]

46. Davenport, C.M.; Teubner, B.J.W.; Han, S.B.; Patton, M.H.; Eom, T.-Y.; Garic, D.; Lansdell, B.J.; Shirinifard, A.; Chang, T.-C.; Klein, J.; et al. Innate frequency-discrimination hyperacuity in Williams-Beuren syndrome mice. *Cell* **2022**, *185*, 3877–3895.e21. [CrossRef] [PubMed]

47. Torres, A.S.; Robison, M.K.; Brewer, G.A. The role of the LC-NE system in attention: From cells, to systems, to sensory-motor control. *Neurosci. Biobehav. Rev.* **2025**, *175*, 106233. [CrossRef]

48. Foote, S.L.; Aston-Jones, G.; Bloom, F.E. Impulse activity of locus coeruleus neurons in awake rats and monkeys is a function of sensory stimulation and arousal. *Proc. Natl. Acad. Sci. USA* **1980**, *77*, 3033–3037. [CrossRef]

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.